CoChat

Metabolic and immunogenetic prediction of long‐term insulin remission in African patients with atypical diabetes

Sobngwi, E., Vexiau, P., Levy, V., Lepage, V., Mauvais‐Jarvis, F., Leblanc, H., Mbanya, J. C., Gautier, J. F. · 2002 · Diabetic Medicine
Cited by 68

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Aims We aimed to characterize a cohort of ‘atypical’ diabetic patients of sub‐Saharan African origin and to analyse possible determinants of long‐term remission. Methods Over 6 years, we studied the clinical and therapeutic profile of 42 consecutive patients undiagnosed or untreated prior to inclusion presenting with cardinal features of diabetes mellitus. We measured insulin secretion and sensitivity at inclusion. Immunogenetic (anti‐GAD, anti‐ICA and HLA class II) markers of Type 1 diabetes were compared with a 90‐non‐diabetic unrelated adult African population. Results Twenty‐one ketonuric patients (age 42 ± 9 (sd) years; body mass index (BMI) 26 ± 3 kg/m 2) were initially insulin‐treated (IT), and 21 non‐ketonuric patients (age 38 ± 8 years; BMI 26 ± 5 kg/m 2) had oral and/or diet therapy (NIT). Insulin could be discontinued in 47.6% (10/21) IT with adequate glycaemic control (HbA 1c 6.7 ± 1.3%), while insulin was secondarily started in 38.1% (8/21) NIT in expectation of better control. The initial basal (odds ratio (OR) 9.1, 95% confidence interval (CI) 1.3–64.4) and stimulated C‐peptide (OR 8.17, 95% CI 1.5–44.1) were independently associated with remission. Insulin resistance was present in all the groups, more marked in the insulin‐treated NIT. Anti‐GAD antibodies and ICA were rare, but 38.1% IT vs. 1.1% controls had Type 1 diabetes HLA susceptibility haplotypes (P < 0.001) without significant difference between the subgroups. Conclusion Prolonged discontinuation of insulin is frequent in African diabetic patients initially presenting with signs of insulinopenia. In our patients, long‐term insulin therapy was not associated with immunogenetic markers of Type 1 diabetes. The initial measure of insulin secretion seemed a good predictor of long‐term remission.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1464-5491.2002.00802.x

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 68

Metadata

Authors
Sobngwi, E., Vexiau, P., Levy, V., Lepage, V., Mauvais‐Jarvis, F., Leblanc, H., Mbanya, J. C., & Gautier, J. F.
Venue
Diabetic Medicine
Publisher
Wiley
Published
2002-10
Volume
19
Issue
10
Pages
832-835
ISSN
  • 0742-3071 (ISSN-L)
  • 1464-5491
OpenAlex
W2019243766
Cited by
68
References
1
FWCI
2.00
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metabolic and immunogenetic prediction of long‐term insulin remission in African patients with atypical diabetes. https://app.cochat.ai/papers/10.1046/j.1464-5491.2002.00802.x
The paper
Sobngwi, E., Vexiau, P., Levy, V., Lepage, V., Mauvais‐Jarvis, F., Leblanc, H., Mbanya, J. C., & Gautier, J. F. (2002). Metabolic and immunogenetic prediction of long‐term insulin remission in African patients with atypical diabetes. Diabetic Medicine. https://doi.org/10.1046/j.1464-5491.2002.00802.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.